Literature DB >> 11948765

Neuropsychological assessment for management of patients with deep brain stimulation.

Bernard Pillon1.   

Abstract

The inclusion of cognitive and behavioural criteria has been recommended for the management of patients with deep brain stimulation. A neuropsychological assessment may contribute to different issues: (1) selection of the best candidates for surgery, (2) evaluation of the consequences of surgery, (3) research of the best electrode implantation. Recent neuropsychological studies indicate that (1) with appropriate inclusion criteria, the effects of surgery on cognitive functions are limited; (2) an aggravation of behavioural disorders might be related to subthalamic nucleus (STN) stimulation and depend on electrode location; (3) subthalamic nucleus stimulation, but not the internal globus pallidus stimulation, improves psychomotor efficiency and working memory. These results would suggest that the implanted electrodes are not solely targeting the motor circuit and that the cognitive and motor circuits are not completely segregated. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2002        PMID: 11948765     DOI: 10.1002/mds.10152

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

1.  Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?

Authors:  V Czernecki; B Pillon; J L Houeto; M L Welter; V Mesnage; Y Agid; B Dubois
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

2.  Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease.

Authors:  V Fraix; J-L Houeto; C Lagrange; C Le Pen; P Krystkowiak; D Guehl; C Ardouin; M-L Welter; F Maurel; L Defebvre; A Rougier; A-L Benabid; V Mesnage; M Ligier; S Blond; P Burbaud; B Bioulac; A Destée; P Cornu; P Pollak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

3.  PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study.

Authors:  Marie-Laure Welter; Adele Demain; Claire Ewenczyk; Virginie Czernecki; Brian Lau; Amine El Helou; Hayat Belaid; Jérôme Yelnik; Chantal François; Eric Bardinet; Carine Karachi; David Grabli
Journal:  J Neurol       Date:  2015-04-23       Impact factor: 4.849

4.  Deep brain stimulation and cognitive decline in Parkinson's disease: a clinical review.

Authors:  João Massano; Carolina Garrett
Journal:  Front Neurol       Date:  2012-04-26       Impact factor: 4.003

5.  Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial.

Authors:  David Maltête; David Wallon; Julie Bourilhon; Romain Lefaucheur; Teodor Danaila; Stéphane Thobois; Luc Defebvre; Kathy Dujardin; Jean-Luc Houeto; Olivier Godefroy; Pierre Krystkowiak; Olivier Martinaud; André Gillibert; Mathieu Chastan; Pierre Vera; Didier Hannequin; Marie-Laure Welter; Stéphane Derrey
Journal:  Neurology       Date:  2020-11-16       Impact factor: 9.910

6.  Rivastigmine for the treatment of dementia associated with Parkinson's disease.

Authors:  Jennifer L Reingold; John C Morgan; Kapil D Sethi
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

7.  Optimal target localization for subthalamic stimulation in patients with Parkinson disease.

Authors:  Marie-Laure Welter; Michael Schüpbach; Virginie Czernecki; Carine Karachi; Sara Fernandez-Vidal; Jean-Louis Golmard; Giulia Serra; Soledad Navarro; Arlette Welaratne; Andréas Hartmann; Valérie Mesnage; Fanny Pineau; Philippe Cornu; Bernard Pidoux; Yulia Worbe; Panayiotis Zikos; David Grabli; Damien Galanaud; Anne-Marie Bonnet; Hayat Belaid; Didier Dormont; Marie Vidailhet; Luc Mallet; Jean-Luc Houeto; Eric Bardinet; Jerome Yelnik; Yves Agid
Journal:  Neurology       Date:  2014-03-19       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.